Amarin | AMRN - EPS Earnings Per Share


Amarin reported $0.08 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.08 0.11 Sep/2025
AstraZeneca USD 2.12 0.26 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 2.04 0.38 Sep/2025